254 related articles for article (PubMed ID: 9325235)
1. Characterization of a specific region in the hepatitis B virus enhancer I for the efficient expression of X gene in the hepatic cell.
Fukai K; Takada S; Yokosuka O; Saisho H; Omata M; Koike K
Virology; 1997 Sep; 236(2):279-87. PubMed ID: 9325235
[TBL] [Abstract][Full Text] [Related]
2. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein.
Zheng Y; Li J; Ou JH
J Virol; 2004 Jul; 78(13):6908-14. PubMed ID: 15194767
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the role of individual protein binding motifs within the hepatitis B virus enhancer I on X promoter activity using linker scanning mutagenesis.
Gustin K; Shapiro M; Lee W; Burk RD
Virology; 1993 Apr; 193(2):653-60. PubMed ID: 8384750
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3.
Chen M; Hieng S; Qian X; Costa R; Ou JH
Virology; 1994 Nov; 205(1):127-32. PubMed ID: 7975208
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus enhancer binds and is activated by the Hepatocyte nuclear factor 3.
Ori A; Shaul Y
Virology; 1995 Feb; 207(1):98-106. PubMed ID: 7871756
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor of activated T cells (NFAT1-C) represses the enhancer II and pregenomic promoter (EnII/Cp) of hepatitis B virus (HBV) through its responsive site GGAGA and nullifies the HBx-driven transcriptional activation.
Lee JH; Rho HM
IUBMB Life; 2001 Apr; 51(4):255-61. PubMed ID: 11569920
[TBL] [Abstract][Full Text] [Related]
7. HNF3 binds and activates the second enhancer, ENII, of hepatitis B virus.
Li M; Xie Y; Wu X; Kong Y; Wang Y
Virology; 1995 Dec; 214(2):371-8. PubMed ID: 8553537
[TBL] [Abstract][Full Text] [Related]
8. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
[TBL] [Abstract][Full Text] [Related]
9. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.
Günther S; Piwon N; Iwanska A; Schilling R; Meisel H; Will H
J Virol; 1996 Dec; 70(12):8318-31. PubMed ID: 8970951
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer I.
Garcia AD; Ostapchuk P; Hearing P
J Virol; 1993 Jul; 67(7):3940-50. PubMed ID: 8389913
[TBL] [Abstract][Full Text] [Related]
11. [On the role of liver-enriched transcription factors in regulating HBV transcription and replication].
Wang S; Tang H; He F; Liu L; Huang FJ; Zhou TY; Zhao LS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):35-9. PubMed ID: 16468637
[TBL] [Abstract][Full Text] [Related]
12. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
14. Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression.
Hatzis P; Talianidis I
Mol Cell Biol; 2001 Nov; 21(21):7320-30. PubMed ID: 11585914
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid stimulates primate but inhibits rodent alpha-fetoprotein gene promoter.
Nakabayashi H; Koyama Y; Sakai M; Li HM; Wong NC; Nishi S
Biochem Biophys Res Commun; 2001 Sep; 287(1):160-72. PubMed ID: 11549270
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and functional properties of a palindromic sequence motif within the hepatitis B virus enhancer 1.
Kosovsky MJ; Siddiqui A
Virology; 1999 Jun; 259(1):60-6. PubMed ID: 10364489
[TBL] [Abstract][Full Text] [Related]
17. Major differences between WHV and HBV in the regulation of transcription.
Di Q; Summers J; Burch JB; Mason WS
Virology; 1997 Mar; 229(1):25-35. PubMed ID: 9123867
[TBL] [Abstract][Full Text] [Related]
18. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
Tacke F; Liedtke C; Bocklage S; Manns MP; Trautwein C
Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of hepatitis B virus transactivator X: implication of the leucine zipper-like region and C-terminal seven conserved amino acids in functional regions.
Kim YH; Kang SK; Lee YI
Biochem Biophys Res Commun; 1993 Dec; 197(2):894-903. PubMed ID: 8267629
[TBL] [Abstract][Full Text] [Related]
20. Interplay between a new HNF3 and the HNF1 transcriptional factors in the duck hepatitis B virus enhancer.
Crescenzo-Chaigne B; Pillot J; Lilienbaum A
Virology; 1995 Oct; 213(1):231-40. PubMed ID: 7483267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
